Fierce Healthcare February 24, 2020
Paige Minemyer

Medicaid managed care organizations (MCOs) saved states and taxpayers billions on prescription drugs in 2018, a new report backed by the insurance industry found.

Consulting firm The Menges Group analyzed the financial performance of MCOs on behalf of America’s Health Insurance Plans (AHIP) and found the private Medicaid plans accounted for $6.5 billion in net savings on drugs in fiscal 2018.

Net costs per prescription in managed care were 27% lower than those for traditional Medicaid, according to the study.

“When states rely on Medicaid managed care plans to provide integrated drug benefits to enrollees, they do even better and deliver more savings for taxpayers every day,” said AHIP CEO Matt Eyles in a statement. “This study...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Market Research, Medicaid, Payer, Pharma, Trends
Reconsidering The No Surprises Act Data: Implications For Policymakers
Instacart inks another healthcare partnership
Where 6 payers' Medicare Advantage businesses are headed in 2025, per their CEOs
BCBS Massachusetts weight loss drug spend jumps 250%: 5 notes
Offering health insurance is becoming less lucrative

Share This Article